Medical Devices
Market intelligence and commercial strategy for medical-device and health-technology companies — including the fast-moving clinical-AI and digital-health frontier.
Medical-device and health-technology companies compete on clinical evidence, reimbursement and channel access as much as on the product itself — and the ground is shifting fastest where software and AI enter the clinic. We help device and health-tech strategy, product and corporate-development teams make market-entry, portfolio and build-buy-partner decisions grounded in real evidence.
How we help Medical Devices teams
- Market-entry and geographic-prioritization strategy
- Competitive intelligence and clinical / regulatory landscape tracking
- Reimbursement and market-access mapping across key markets
- Build-buy-partner strategy for new capabilities, including clinical AI
- Commercial due diligence for acquisitions and partnerships
Questions we help answer
- Which markets and segments should we enter first, and how?
- Where is reimbursement real enough to build a business case on?
- Should we build, buy or partner for this capability?
- How does our offer compare on evidence, access and channel strength?
How we work
Every engagement is designed around a specific decision and delivered by sector-specialist analysts, with transparent assumptions and Excel- or dashboard-backed models you can interrogate. We draw on the proprietary research infrastructure of the InsightAce Analytic group and tailor each output to how your team actually makes decisions.